[Ocusert. Synopsis of a round-table discussion].
D006801:Humans; D009883:Ophthalmic Solutions; D014677:Pharmaceutical Vehicles / Q000009:adverse effects / Q000592:standards; D010862:Pilocarpine / Q000008:administration & dosage
D009883:Ophthalmic Solutions; D014677:Pharmaceutical Vehicles; D010862:Pilocarpine
Ocusert Zusammenfassung eines Rundtischgespräches